Efficacy of a hypnosis-based intervention to improve well-being during cancer: a comparison between prostate and breast cancer patients

C Grégoire, H Nicolas, I Bragard, F Delevallez, I Merckaert, D Razavi, D Waltregny, M-E Faymonville, A Vanhaudenhuyse, C Grégoire, H Nicolas, I Bragard, F Delevallez, I Merckaert, D Razavi, D Waltregny, M-E Faymonville, A Vanhaudenhuyse

Abstract

Background: Prostate and breast cancer can have a lot of negative consequences such as fatigue, sleep difficulties and emotional distress, which decrease quality of life. Group interventions showed benefits to emotional distress and fatigue, but most of these studies focus on breast cancer patients. However, it is important to test if an effective intervention for breast cancer patients could also have benefits for prostate cancer patients.

Methods: Our controlled study aimed to compare the efficacy of a self-hypnosis/self-care group intervention to improve emotional distress, sleep difficulties, fatigue and quality of life of breast and prostate cancer patients. 25 men with prostate cancer and 68 women with breast cancer participated and were evaluated before (T0) and after (T1) the intervention.

Results: After the intervention, the breast cancer group showed positive effects for anxiety, depression, fatigue, sleep difficulties, and global health status, whereas there was no effect in the prostate cancer group. We showed that women suffered from higher difficulties prior to the intervention and that their oncological treatments were different in comparison to men.

Conclusion: The differences in the efficacy of the intervention could be explained by the baseline differences. As men in our sample reported few distress, fatigue or sleep problems, it is likely that they did not improve on these dimensions.

Trial registration: ClinicalTrials.gov ( NCT02569294 and NCT03423927 ). Retrospectively registered in October 2015 and February 2018 respectively.

Keywords: Breast cancer; Group intervention; Hypnosis; Prostate cancer; Self-care.

Conflict of interest statement

Ethics approval and consent to participate

All procedures performed in this study were in accordance with the ethical standards of the institutional and national research committees and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.

The study was approved by the Ethics Committee of the Faculty of Medicine of the University of Liège, with each participant providing written consent.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

    1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90. doi: 10.3322/caac.20107.
    1. Kanso C, Etner J, Debré B, Zerbib M. Cancer de la prostate : aspects médicoéconomiques. Prog En Urol. 2012:85–90.
    1. Kibel AS, Ciezki JP, Klein EA, Reddy CA, Lubahn JD, Haslag-Minoff J, et al. Survival among men with clinically localized prostate cancer treated with radical prostatectomy or radiation therapy in the prostate specific antigen era. J Urol. 2012;187:1259–1265. doi: 10.1016/j.juro.2011.11.084.
    1. Kim HS, Freedland SJ. Androgen deprivation therapy in prostate cancer: anticipated side-effects and their management. Curr Opin Support Palliat Care. 2010;4:147–152. doi: 10.1097/SPC.0b013e32833bd913.
    1. Baade PD, Youlden DR, Krnjacki LJ. International epidemiology of prostate cancer: geographical distribution and secular trends. Mol Nutr Food Res. 2009;53:171–184. doi: 10.1002/mnfr.200700511.
    1. DeSantis C, Ma J, Bryan L, Jemal A. Breast cancer statistics, 2013. CA Cancer J Clin. 2014;64:52–62. doi: 10.3322/caac.21203.
    1. Visser A. Cancer in a psychosomatic perspective. Somat Psychosom symptoms [internet]. Springer, New York, NY; 2013 [cited 2017 Oct 17]. p. 225–38. Available from: .
    1. McDowell ME, Occhipinti S, Ferguson M, Dunn J, Chambers SK. Predictors of change in unmet supportive care needs in cancer. Psychooncology. 2010;19:508–516. doi: 10.1002/pon.1604.
    1. Holmes JA, Wang AZ, Hoffman KE, Hendrix LH, Rosenman JG, Carpenter WR, et al. Is primary prostate cancer treatment influenced by likelihood of extraprostatic disease? A surveillance, epidemiology and end results patterns of care study. Int J Radiat Oncol Biol Phys. 2012;84:88–94. doi: 10.1016/j.ijrobp.2011.10.076.
    1. Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012;62:220–241. doi: 10.3322/caac.21149.
    1. Physician Data Query Adult Treatment Editorial Board . Breast Cancer Treatment (PDQ®): Patient Version. PDQ Cancer Inf Summ [Internet] Bethesda: National Cancer Institute (US); 2002.
    1. Carter N, Bryant-Lukosius D, DiCenso A, Blythe J, Neville AJ. The supportive care needs of men with advanced prostate Cancer. Oncol Nurs Forum. 2011;38:189–198. doi: 10.1188/11.ONF.189-198.
    1. Die Trill M. Anxiety and sleep disorders in cancer patients. EJC Suppl. 2013;11:216–224. doi: 10.1016/j.ejcsup.2013.07.009.
    1. Ewertz M, Jensen AB. Late effects of breast cancer treatment and potentials for rehabilitation. Acta Oncol Stockh Swed. 2011;50:187–193. doi: 10.3109/0284186X.2010.533190.
    1. Fransson P. Fatigue in prostate cancer patients treated with external beam radiotherapy: a prospective 5-year long-term patient-reported evaluation. J Cancer Res Ther. 2010;6:516–520. doi: 10.4103/0973-1482.77076.
    1. Miaskowski C, Paul SM, Cooper BA, Lee K, Dodd M, West C, et al. Predictors of the trajectories of self-reported sleep disturbance in men with prostate cancer during and following radiation therapy. Sleep. 2011;34:171–179. doi: 10.1093/sleep/34.2.171.
    1. Selli C, Bjartell A, Burgos J, Somerville M, Palacios J-M, Benjamin L, et al. Burden of illness in prostate Cancer patients with a low-to-moderate risk of progression: a one-year, pan-European observational study. Prostate Cancer. 2014;2014:e472949. doi: 10.1155/2014/472949.
    1. Weis J, Horneber M. Cancer-Related Fatigue [Internet]. Tarporley: Springer Healthcare Ltd.; 2015 [cited 2016 Dec 2]. Available from: .
    1. Gonzalez BD, Jim HSL, Booth-Jones M, Small BJ, Sutton SK, Lin H-Y, et al. Course and predictors of cognitive function in patients with prostate Cancer receiving androgen-deprivation therapy: a controlled comparison. J Clin Oncol. 2015;33:2021–2027. doi: 10.1200/JCO.2014.60.1963.
    1. Hutchinson AD, Hosking JR, Kichenadasse G, Mattiske JK, Wilson C. Objective and subjective cognitive impairment following chemotherapy for cancer: a systematic review. Cancer Treat Rev. 2012;38:926–934. doi: 10.1016/j.ctrv.2012.05.002.
    1. Jim HSL, Phillips KM, Chait S, Faul LA, Popa MA, Lee Y-H, et al. Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy. J Clin Oncol Off J Am Soc Clin Oncol. 2012;30:3578–3587. doi: 10.1200/JCO.2011.39.5640.
    1. Kesler SR, Adams M, Packer M, Rao V, Henneghan AM, Blayney DW, et al. Disrupted brain network functional dynamics and hyper-correlation of structural and functional connectome topology in patients with breast cancer prior to treatment. Brain Behav. 2017;7 Available from:
    1. McGinty HL, Phillips KM, Jim HSL, Cessna JM, Asvat Y, Cases MG, et al. Cognitive functioning in men receiving androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis. Support Care Cancer. 2014;22:2271–2280. doi: 10.1007/s00520-014-2285-1.
    1. Wu L, Tanenbaum ML, Dijkers MPJM, Amidi A, Hall SJ, Penedo FJ, et al. Cognitive and neurobehavioral symptoms in patients with non-metastatic prostate cancer treated with androgen deprivation therapy or observation: a mixed methods study. Soc Sci Med. 2016;156:80–9.
    1. Hernández Blázquez M, Cruzado JA. A longitudinal study on anxiety, depressive and adjustment disorder, suicide ideation and symptoms of emotional distress in patients with cancer undergoing radiotherapy. J Psychosom Res. 2016;87:14–21. doi: 10.1016/j.jpsychores.2016.05.010.
    1. Jayadevappa R, Malkowicz SB, Chhatre S, Johnson JC, Gallo JJ. The burden of depression in prostate cancer. Psychooncology. 2012;21:1338–1345. doi: 10.1002/pon.2032.
    1. Thornton AA, Perez MA, Oh S, Crocitto L. A prospective report of changes in prostate cancer related quality of life after robotic prostatectomy. J Psychosoc Oncol. 2011;29:157–167. doi: 10.1080/07347332.2010.548669.
    1. Tojal C, Costa R. Depressive symptoms and mental adjustment in women with breast cancer. Psychooncology. 2015;24:1060–1065. doi: 10.1002/pon.3765.
    1. Watts S, Leydon G, Birch B, Prescott P, Lai L, Eardley S, et al. Depression and anxiety in prostate cancer: a systematic review and meta-analysis of prevalence rates. BMJ Open. 2014;4:e003901. doi: 10.1136/bmjopen-2013-003901.
    1. Lindbohm M-L, Kuosma E, Taskila T, Hietanen P, Carlsen K, Gudbergsson S, et al. Cancer as the cause of changes in work situation (a NOCWO study) Psychooncology. 2011;20:805–812. doi: 10.1002/pon.1797.
    1. Lindbohm M-L, Taskila T, Kuosma E, Hietanen P, Carlsen K, Gudbergsson S, et al. Work ability of survivors of breast, prostate, and testicular cancer in Nordic countries: a NOCWO study. J Cancer Surviv Res Pract. 2012;6:72–81. doi: 10.1007/s11764-011-0200-z.
    1. Sharp L, Timmons A. Social welfare and legal constraints associated with work among breast and prostate cancer survivors: experiences from Ireland. J Cancer Surviv Res Pract. 2011;5:382–394. doi: 10.1007/s11764-011-0183-9.
    1. Chung E, Brock G. Sexual rehabilitation and Cancer survivorship: a state of art review of current literature and management strategies in male sexual dysfunction among prostate Cancer survivors. J Sex Med. 2013;10:102–111. doi: 10.1111/j.1743-6109.2012.03005.x.
    1. Donovan KA, Walker LM, Wassersug RJ, Thompson LMA, Robinson JW. Psychological effects of androgen-deprivation therapy on men with prostate cancer and their partners. Cancer. 2015;121:4286–4299. doi: 10.1002/cncr.29672.
    1. Howlett K, Koetters T, Edrington J, West C, Paul S, Lee K, et al. Changes in sexual function on mood and quality of life in patients undergoing radiation therapy for prostate Cancer. Oncol Nurs Forum. 2009;37:E58–E66. doi: 10.1188/10.ONF.E58-E66.
    1. Smith DP, King MT, Egger S, Berry MP, Stricker PD, Cozzi P, et al. Quality of life three years after diagnosis of localised prostate cancer: population based cohort study. BMJ. 2009;339:b4817. doi: 10.1136/bmj.b4817.
    1. Ussher JM, Perz J, Hawkins Y, Brack M. Evaluating the efficacy of psycho-social interventions for informal carers of cancer patients: a systematic review of the research literature. Health Psychol Rev. 2009;3:85–107. doi: 10.1080/17437190903033401.
    1. Huang GJ, Sadetsky N, Penson DF. Health related quality of life for men treated for localized prostate cancer with long-term followup. J Urol. 2010;183:2206–2212. doi: 10.1016/j.juro.2010.02.013.
    1. Prabhu V, Sivarajan G, Taksler GB, Laze J, Lepor H. Long-term continence outcomes in men undergoing radical prostatectomy for clinically localized prostate Cancer. Eur Urol. 2014;65:52–57. doi: 10.1016/j.eururo.2013.08.006.
    1. Karabulut N, Erci B. Sexual desire and satisfaction in sexual life affecting factors in breast cancer survivors after mastectomy. J Psychosoc Oncol. 2009;27:332–343. doi: 10.1080/07347330902979101.
    1. Park HY, Kim JH, Choi S, Kang E, Oh S, Kim JY, et al. Psychological effects of a cosmetic education programme in patients with breast cancer. J Cancer Care. 2015;24:493–502. doi: 10.1111/ecc.12290.
    1. Manne S, Badr H, Zaider T, Nelson C, Kissane D. Cancer-related communication, relationship intimacy, and psychological distress among couples coping with localized prostate cancer. J Cancer Surviv. 2010;4:74–85. doi: 10.1007/s11764-009-0109-y.
    1. Northouse LL, Katapodi MC, Schafenacker AM, Weiss D. The impact of caregiving on the psychological well-being of family caregivers and Cancer patients. Semin Oncol Nurs. 2012;28:236–245. doi: 10.1016/j.soncn.2012.09.006.
    1. Goldsmith DJ, Miller GA. Conceptualizing how couples talk about Cancer. Health Commun. 2014;29:51–63. doi: 10.1080/10410236.2012.717215.
    1. Martin E, Bulsara C, Battaglini C, Hands B, Naumann FL. Breast and prostate cancer survivor responses to group exercise and supportive group psychotherapy. J Psychosoc Oncol. 2015;33:620–634. doi: 10.1080/07347332.2015.1082166.
    1. Mériaux E, Joly F. Cancer de la prostate : effets secondaires des traitements sur la masculinité (identité masculine, fertilité, sexualité) Psycho-Oncol. 2017;11:134–137. doi: 10.1007/s11839-017-0632-4.
    1. Davis KM, Kelly SP, Luta G, Tomko C, Miller AB, Taylor KL. The Association of Long-term Treatment-related Side Effects with Cancer-specific and General Quality of life among prostate Cancer survivors. Urology. 2014;84:300–306. doi: 10.1016/j.urology.2014.04.036.
    1. Holden AEC, Ramirez AG, Gallion K. Depressive symptoms in Latina breast cancer survivors: a barrier to cancer screening. Health Psychol Off J Div Health Psychol Am Psychol Assoc. 2014;33:242–248.
    1. Jones JM, Olson K, Catton P, Catton CN, Fleshner NE, Krzyzanowska MK, et al. Cancer-related fatigue and associated disability in post-treatment cancer survivors. J Cancer Surviv. 2016;10:51–61. doi: 10.1007/s11764-015-0450-2.
    1. Resnick MJ, Koyama T, Fan K-H, Albertsen PC, Goodman M, Hamilton AS, et al. Long-term functional outcomes after treatment for localized prostate Cancer. N Engl J Med. 2013;368:436–445. doi: 10.1056/NEJMoa1209978.
    1. Taylor KL, Luta G, Miller AB, Church TR, Kelly SP, Muenz LR, et al. Long-term disease-specific functioning among prostate Cancer survivors and noncancer controls in the prostate, lung, colorectal, and ovarian Cancer screening trial. J Clin Oncol. 2012;30:2768–2775. doi: 10.1200/JCO.2011.41.2767.
    1. Grégoire C, Bragard I, Jerusalem G, Etienne A-M, Coucke P, Dupuis G, et al. Group interventions to reduce emotional distress and fatigue in breast cancer patients: a 9-month follow-up pragmatic trial. Br J Cancer. 2017;117(10):bjc2017326.
    1. Hammond DC. Hypnosis in the treatment of anxiety- and stress-related disorders. Expert Rev Neurother. 2010;10:263–273. doi: 10.1586/ern.09.140.
    1. Faller H, Schuler M, Richard M, Heckl U, Weis J, Küffner R. Effects of psycho-oncologic interventions on emotional distress and quality of life in adult patients with cancer: systematic review and meta-analysis. J Clin Oncol Off J Am Soc Clin Oncol. 2013;31:782–793. doi: 10.1200/JCO.2011.40.8922.
    1. de Vries M, Stiefel F. Psycho-Oncological Interventions and Psychotherapy in the Oncology Setting. In: Goerling U, editor. Psychooncology [Internet]. Berlin, Heidelberg: Springer Berlin Heidelberg; 2014. p. 121–135 [cited 2016 Dec 2]. Available from: .
    1. Mitchell SA, Hoffman AJ, Clark JC, DeGennaro RM, Poirier P, Robinson CB, et al. Putting evidence into practice: an update of evidence-based interventions for Cancer-related fatigue during and following treatment. Clin J Oncol Nurs. 2014;18:38–58. doi: 10.1188/14.CJON.S3.38-58.
    1. Montgomery GH, David D, Kangas M, Green S, Sucala M, Bovbjerg DH, et al. Randomized controlled trial of a cognitive-behavioral therapy plus hypnosis intervention to control fatigue in patients undergoing radiotherapy for breast Cancer. J Clin Oncol. 2014;32:557–563. doi: 10.1200/JCO.2013.49.3437.
    1. Cramer H, Lauche R, Paul A, Langhorst J, Kümmel S, Dobos GJ. Hypnosis in breast cancer care: a systematic review of randomized controlled trials. Integr Cancer Ther. 2015;14:5–15. doi: 10.1177/1534735414550035.
    1. Gudenkauf LM, Antoni MH, Stagl JM, Lechner SC, Jutagir DR, Bouchard LC, et al. Brief cognitive-behavioral and relaxation training interventions for breast cancer: a randomized controlled trial. J Consult Clin Psychol. 2015;83:677–688. doi: 10.1037/ccp0000020.
    1. Visser A, van Andel G. Psychosocial and educational aspects in prostate cancer patients. Patient Educ Couns. 2003;49:203–206. doi: 10.1016/S0738-3991(03)00024-7.
    1. Keogh JWL, MacLeod RD. Body composition, physical fitness, functional performance, quality of life, and fatigue benefits of exercise for prostate Cancer patients: a systematic review. J Pain Symptom Manag. 2012;43:96–110. doi: 10.1016/j.jpainsymman.2011.03.006.
    1. Chipperfield K, Brooker J, Fletcher J, Burney S. The impact of physical activity on psychosocial outcomes in men receiving androgen deprivation therapy for prostate cancer: a systematic review. Health Psychol. 2014;33:1288–1297. doi: 10.1037/hea0000006.
    1. Gardner JR, Livingston PM, Fraser SF. Effects of exercise on treatment-related adverse effects for patients with prostate Cancer receiving androgen-deprivation therapy: a systematic review. J Clin Oncol. 2014;32:335–346. doi: 10.1200/JCO.2013.49.5523.
    1. Larkin D, Lopez V, Aromataris E. Managing cancer-related fatigue in men with prostate cancer: a systematic review of non-pharmacological interventions. J Nurs Pract. 2014;20:549–560. doi: 10.1111/ijn.12211.
    1. Chambers SK, Pinnock C, Lepore SJ, Hughes S, O’Connell DL. A systematic review of psychosocial interventions for men with prostate cancer and their partners. Patient Educ Couns. 2011;85:e75–e88. doi: 10.1016/j.pec.2011.01.027.
    1. Newby TA, Graff JN, Ganzini LK, McDonagh MS. Interventions that may reduce depressive symptoms among prostate cancer patients: a systematic review and meta-analysis. Psychooncology. 2015;24:1686–1693. doi: 10.1002/pon.3781.
    1. Bragard I, Etienne A-M, Faymonville M-E, Coucke P, Lifrange E, Schroeder H, et al. A non-randomized comparison study of self-hypnosis, yoga and cognitive behavioral therapy to reduce emotional distress in breast cancer patients. Int J Clin Exp Hypn. 2017 [cited 2017 Jan 13]; Available from: .
    1. Vanhaudenhuyse A, Gillet A, Malaise N, Salamun I, Barsics C, Grosdent S, et al. Efficacy and cost-effectiveness: a study of different treatment approaches in a tertiary pain Centre. Eur J Pain Lond Engl. 2015;19:1437–1446. doi: 10.1002/ejp.674.
    1. Vanhaudenhuyse A, Gillet A, Malaise N, Salamun I, Grosdent S, Maquet D, et al. Psychological interventions influence patients’ attitudes and beliefs about their chronic pain. J Tradit Complement Med. 2017 [cited 2017 Nov 21]; Available from: .
    1. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–370. doi: 10.1111/j.1600-0447.1983.tb09716.x.
    1. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–376. doi: 10.1093/jnci/85.5.365.
    1. Savard M-H, Savard J, Simard S, Ivers H. Empirical validation of the insomnia severity index in cancer patients. Psychooncology. 2005;14:429–441. doi: 10.1002/pon.860.
    1. Cohen J. Statistical power analysis for the behavioral sciences. Massachusetts: Academic Press; 1977.
    1. Nolen-Hoeksema S. Gender Differences in Depression. Curr Dir Psychol Sci. 2001;10:173–176. doi: 10.1111/1467-8721.00142.
    1. Linden W, Vodermaier A, MacKenzie R, Greig D. Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age. J Affect Disord. 2012;141:343–351. doi: 10.1016/j.jad.2012.03.025.
    1. Bhattacharjee A, Banerjee A. State and trait anxiety among cancer patients: a comparative analysis. J Psychosoc Res. 2016;11:427–436.
    1. Stapleton SJ, Valerio TD, Astroth KS, Woodhouse S. Distress during radiation therapy: assessment among patients with breast or prostate cancer. J Oncol Nurs. 2017;21:93–98. doi: 10.1188/17.CJON.93-98.
    1. Tang Y, Yang W, Wang Y-L, Lin L. Sex differences in the symptoms and psychological factors that influence quality of life in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol. 2012;24:702–707. doi: 10.1097/MEG.0b013e328351b2c2.
    1. Alosaimi FD, Al-Sultan OA, Alghamdi QA, Almohaimeed IK, Alqannas SI. Gender-specific differences in depression and anxiety symptoms and help-seeking behavior among gastroenterology patients in Riyadh, Saudi Arabia. Neurosci Riyadh Saudi Arab. 2014;19:203–209.
    1. McLean CP, Asnaani A, Litz BT, Hofmann SG. Gender differences in anxiety disorders: prevalence, course of illness, comorbidity and burden of illness. J Psychiatr Res. 2011;45:1027–1035. doi: 10.1016/j.jpsychires.2011.03.006.
    1. Mo PKH, Malik SH, Coulson NS. Gender differences in computer-mediated communication: a systematic literature review of online health-related support groups. Patient Educ Couns. 2009;75:16–24. doi: 10.1016/j.pec.2008.08.029.
    1. Nekolaichuk CL, Cumming C, Turner J, Yushchyshyn A, Sela R. Referral patterns and psychosocial distress in cancer patients accessing a psycho-oncology counseling service. Psychooncology. 2011;20:326–332. doi: 10.1002/pon.1765.
    1. Owen JE, Klapow JC, Roth DL, Tucker DC. Use of the internet for information and support: disclosure among persons with breast and prostate cancer. J Behav Med. 2004;27:491–505. doi: 10.1023/B:JOBM.0000047612.81370.f7.
    1. Rosenberg JP. Circles in the surf: Australian masculinity, mortality and grief. Crit Public Health. 2009;19:417–426. doi: 10.1080/09581590902906203.
    1. Sanson-Fisher R, Girgis A, Boyes A, Bonevski B, Burton L, Cook P. The unmet supportive care needs of patients with cancer. Supportive Care Review Group. Cancer. 2000;88:226–237. doi: 10.1002/(SICI)1097-0142(20000101)88:1<226::AID-CNCR30>;2-P.
    1. Halbert CH, Wrenn G, Weathers B, Delmoor E, Ten Have T, Coyne JC. Sociocultural determinants of men’s reactions to prostate cancer diagnosis. Psychooncology. 2010;19:553–560. doi: 10.1002/pon.1574.
    1. Helgason AR, Dickman PW, Adolfsson J, Steineck G. Emotional isolation: prevalence and the effect on well-being among 50-80-year-old prostate cancer patients. Scand J Urol Nephrol. 2001;35:97–101. doi: 10.1080/003655901750170407.
    1. Clover KA, Mitchell AJ, Britton B, Carter G. Why do oncology outpatients who report emotional distress decline help? Psychooncology. 2015;24:812–818. doi: 10.1002/pon.3729.
    1. Blank TO. Schmidt SD, Vangsness SA, Monteiro AK, Santagata PV. Differences among breast and prostate cancer online support groups. Comput Hum Behav. 2010;26:1400–1404. doi: 10.1016/j.chb.2010.04.016.
    1. Knols R, Aaronson NK, Uebelhart D, Fransen J, Aufdemkampe G. Physical exercise in cancer patients during and after medical treatment: a systematic review of randomized and controlled clinical trials. J Clin Oncol Off J Am Soc Clin Oncol. 2005;23:3830–3842. doi: 10.1200/JCO.2005.02.148.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する